TGA-2023-0047-V447
Type IB variation for application TGA-2023-0047. Type IB variation: Formulation Change for Lecanemabix — critical change
Variation Number
TGA-2023-0047-V447
Type
Type IB
Application
Change
Status
Submitted
Fee
€3,197
Submitted
—
Approved
—
Description
Type IB variation: Formulation Change for Lecanemabix — critical change